Guenther Koehne, MD
Medical Oncology · Miami, FLNPI 1679791818
Payments from drug & device makers
Across 190 payments — averaging $5247.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$684K
- Bristol Myers Squibb$86K
- Jazz Pharmaceuticals Inc.$57K
- Karyopharm Therapeutics Inc.$41K
- Redhill Biopharma Inc.$39K
- ADC Therapeutics America, Inc.$37K
- plus $54K from 15 others
Across 14 payments — averaging $832.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$11K
- Eli Lilly$271
What the payments were for
- Consulting fees$7,12019%
- Speaking & faculty fees$26,13469%
- Travel & lodging$2,2376%
- Food & beverage$2,0846%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 103 | $684,003 |
| Bristol Myers Squibb | 6 | $85,533 |
| Jazz Pharmaceuticals Inc. | 6 | $57,318 |
| Karyopharm Therapeutics Inc. | 6 | $40,516 |
| Redhill Biopharma Inc. | 9 | $39,080 |
| ADC Therapeutics America, Inc. | 4 | $36,509 |
| Astellas Pharma US Inc | 16 | $27,877 |
| Janssen Research & Development, LLC | 18 | $13,670 |
| Eli Lilly | 2 | $5,826 |
| Gamida Cell Inc. | 2 | $2,825 |
| Janssen Scientific Affairs, LLC | 2 | $2,080 |
| Astellas Pharma Global Development | 1 | $648 |
| Eurofins Viracor, LLC | 1 | $283 |
| AstraZeneca | 2 | $234 |
| Sanofi | 2 | $142 |
| Johnson & Johnson | 3 | $106 |
| Gilead | 2 | $94 |
| Sumitomo Pharma America, Inc. | 1 | $74 |
| Adaptive Biotechnologies Corporation | 1 | $64 |
| GSK | 2 | $44 |
| Seagen Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$996,963 in reported general payments places this provider in the 80th percentile of 507 medical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Miami
- Jonathan TrentMiami$6.6M
- Neil LoveMiami$5.6M
- Leonel Hernandez AyaMiami$2.8M
- Craig MoskowitzMiami$2.7M
- Gilberto LopesMiami$2.4M
- Damian GreenMiami$2.1M
- Zeynep ErogluTampa$30.9M
- Manish PatelSarasota$29.7M
- Jad ChahoudTampa$21.8M
- Maen HusseinTavares$18.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.